Evaluation of the effectiveness of Methocarbamol in the treatment ofspasticity in people with spinal cord injury.

zdrowisko Kamien Pomorski S.A.0 个研究点目标入组 30 人开始时间: 2022年9月29日最近更新: 2024年8月12日

试验速览

暂无简介。

•a history of spinal cord injury;
•the presence of increased muscle tension on the Ashwort scale 2 to 4;
•time since injury: 3 months;
•the patient must be circulatory and respiratory efficient, alert and aware; adapted to a vertical position;
•a patient with complete and incomplete spinal cord injury, in the cervical, thoracic and lumbar spine, in whom the flexion and extension function will be maintained in the elbow and wrist joints;
•preserved spine stabilization, stabilization of the anastomosis after surgery, completed bone union;
•no contraindications to rehabilitation, such as thrombophlebitis, pulmonary embolism, orthostatic drops in blood pressure, epilepsy, infection.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 25
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 5

•the patient's use of a myorelaxant other than methocarbamol;
•the patient's use of botulinum toxin;
•tetraplegia;
•joint contractures preventing rehabilitation with robots and other contraindications to robotic therapy, such as severe osteoporosis, circulatory and respiratory system disorders, skin lesions, thrombophlebitis, pulmonary embolism, orthostatic drops in blood pressure, epilepsy, infection;
•the presence of open, oozing bedsores;
•malnutrition, wasting of the body (muscle atrophy of the paralyzed without signs of malnutrition and wasting of the body are not the cause of exclusion);
•lack of the patient's informed consent;
•pregnancy or breast-feeding.

发起方

zdrowisko Kamien Pomorski S.A.